Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01076569 · ClinicalTrials.gov registry record
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 250
- Enrollment target
NCT01076569 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 250 participants.
The verdict
NCT01076569 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
This pilot research trial studies biomarkers in bone marrow samples from pediatric patients with high risk acute myeloid leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2010-03 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01076569
The ClinicalTrials.gov registry entry for NCT01076569 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01076569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01076569 about?
NCT01076569 is a clinical study titled "Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia". This pilot research trial studies biomarkers in bone marrow samples from pediatric patients with high risk acute myeloid leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
What is the current status of trial NCT01076569?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2010-03. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01076569?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01076569?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.